Institute for Experimental Cardiovascular Medicine,
University Heart Center Freiburg-Bad Krozingen,
Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen
Peter Kohl studied Medicine and Biophysics at the Moscow Pirogov Institute and, after post-graduate training and research at the Berlin Charité (PhD 1990, Facharzt 1991), he joined the Cardiac Electrophysiology Chair of Professor Denis Noble at Oxford University. In 1998, Peter set up the Oxford Cardiac Mechano-Electric Feedback lab, initially as a Royal Society Research Fellow, and subsequently as a Senior Fellow of the British Heart Foundation. While at Oxford, he held a Research Fellowship at Keble College (2002-2004) and was the Tutorial Fellow in Biomedical Sciences at Balliol (2004-2010). In 2010, he took up the Chair in Cardiac Biophysics and Systems Biology at the Imperial College London. Since 2015, he directs the newly established Institute for Experimental Cardiovascular Medicine at Freiburg. Peter directs a significant portfolio of externally-funded research (supported, among others, by European Research Council, Deutsche Forschungsgemeinschaft, and British Heart Foundation). He has been a driver of international collaboration actions, such as the Network of Excellence for the EU Virtual Physiological Human Initiative, whose co-founding director he was. He serves on editorial boards and as a reviewer for international journals, funding bodies, and faculty promotion committees. Peter is the coordinating editor of the primary textbook on Cardiac Mechano-Electric Coupling and Arrhythmias, and he chairs the leading international workshop series on the same topic.
The Living Scar--Cardiac Fibroblasts and the Injured Heart.
Trends in molecular medicine Feb, 2016 | Pubmed ID: 26776094
Cardiac Mechano-Gated Ion Channels and Arrhythmias.
Circulation research Jan, 2016 | Pubmed ID: 26838316
Editorial to "Disturbances of cardiac wavelength and repolarization precede torsade de pointes and ventricular fibrillation in langendorff perfused rabbit hearts" by Luc Hondeghem: It is difficult to make predictions, especially about the future∗: Thoughts about forecasting cardiotoxicity of pharmacological interventions.
Progress in biophysics and molecular biology 05, 2016 | Pubmed ID: 27137834
Electrotonic coupling of excitable and nonexcitable cells in the heart revealed by optogenetics.
Proceedings of the National Academy of Sciences of the United States of America 12, 2016 | Pubmed ID: 27930302
Sodium permeable and "hypersensitive" TREK-1 channels cause ventricular tachycardia.
EMBO molecular medicine 04, 2017 | Pubmed ID: 28242754
Cardiac fibroblasts : Active players in (atrial) electrophysiology?
Herzschrittmachertherapie & Elektrophysiologie Mar, 2018 | Pubmed ID: 29392412
Potassium channel-based optogenetic silencing.
Nature communications 11, 2018 | Pubmed ID: 30397200
Progress in biophysics and molecular biology: A brief history of the journal.
Progress in biophysics and molecular biology 12, 2018 | Pubmed ID: 30526959
Editorial.
Progress in biophysics and molecular biology 01, 2019 | Pubmed ID: 30902321
Human Atrial Fibroblast Adaptation to Heterogeneities in Substrate Stiffness.
Frontiers in physiology , 2019 | Pubmed ID: 31998137
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。